Provided by Tiger Trade Technology Pte. Ltd.

Spire

84.04
+0.12000.14%
Post-market: 84.040.00000.00%17:45 EST
Volume:450.55K
Turnover:37.86M
Market Cap:4.97B
PE:19.23
High:84.68
Open:84.14
Low:83.30
Close:83.92
52wk High:91.11
52wk Low:64.44
Shares:59.10M
Float Shares:57.58M
Volume Ratio:0.98
T/O Rate:0.78%
Dividend:3.18
Dividend Rate:3.78%
EPS(TTM):4.37
EPS(LYR):4.39
ROE:8.21%
ROA:3.01%
PB:1.58
PE(LYR):19.16

Loading ...

BRIEF-Spire Q4 EPS USD -0.74

Reuters
·
Nov 14

Spire Inc - Expects Fiscal 2026 Adjusted EPS to Be in a Range of $5.25 to $5.45

THOMSON REUTERS
·
Nov 14

Spire Inc - Sets Fiscal 2027 Adj EPS Guidance at $5.65-$5.85

THOMSON REUTERS
·
Nov 14

Spire - 10-Year Capital Investment Target Supports Co's Long-Term Adj EPS Growth of 5–7% Using Fiscal 2027 Adj EPS Guidance Midpoint of $5.75 as Base

THOMSON REUTERS
·
Nov 14

Spire Inc - Raises 10-Year Capital Investment Target to $11.2 Bln

THOMSON REUTERS
·
Nov 14

Spire Q4 Net Income USD -39.8 Million

THOMSON REUTERS
·
Nov 14

Spire Reports Fiscal 2025 Results

THOMSON REUTERS
·
Nov 14

U.S. RESEARCH ROUNDUP-Disney, Enanta Pharmaceuticals, Phillips 66

Reuters
·
Nov 14

Applied Materials, Spire And 3 Stocks To Watch Heading Into Friday

Benzinga
·
Nov 14

Dow Tumbles Around 800 Points On US Government Reopening Day; Investor Fear Increases, Greed Index Moves To 'Extreme Fear' Zone

Benzinga
·
Nov 14

Spire Inc : Jefferies Raises Target Price to $103 From $92

THOMSON REUTERS
·
Nov 14

Spire Raises Dividend by 5.1%

Dow Jones
·
Nov 14

Spire raises quarterly dividend 5.1% o 82.5c per share

TIPRANKS
·
Nov 14

Spire Increases Quarterly Dividend to $0.825 a Share; Payable Jan. 5, 2026, to Shareholders of Record Dec. 11

MT Newswires Live
·
Nov 14

Spire Inc. raises annual common stock dividend to $3.30 per share

Reuters
·
Nov 14

Spire Increases Common Stock Dividend

THOMSON REUTERS
·
Nov 14

Spire Inc - Increases Annual Dividend to $3.30 per Share

THOMSON REUTERS
·
Nov 14

How To Earn $500 A Month From Spire Stock Ahead Of Q4 Earnings

Benzinga
·
Nov 13

Milestone Pharmaceuticals to Present New Analysis from Investigational Etripamil Nasal Spray Clinical Trials for PSVT at the American Heart Association Scientific Sessions 2025

GlobeNewswire
·
Nov 03

Will Regulatory Tailwinds and Tennessee Acquisition Change Spire's (SR) Growth Narrative?

Simply Wall St.
·
Nov 01